AzTrials
AzTrials

Cardiac Arrest (CA)NCT07875348

Integrated Near-Infrared Spectroscopy and Hemodynamic Monitoring for Cerebral Autoregulation in Post-Cardiac Arrest Care Neuroprognostication

An observational study of Cardiac Arrest (CA), run by National Taiwan University Hospital at 1 site in Taiwan.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record

Search all trials

Trial summary

Neurological outcome is the primary outcome for post-cardiac arrest patients. Hypoxic-ischemic brain injury is a key element in post-cardiac arrest syndrome, and remains the leading cause of mortality and morbidity in post-cardiac arrest patients. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cardiac Arrest (CA)
How many people
60 participants
Where
1 siteTaiwan
Study dates
Jan 2027to 31 Dec 2029
Phase
Observational

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: post-cardiac arrest patients admitted to ICU

Who may be able to join

  • non-traumatic cardiac arrest
  • admitted to ICU
  • unable to follow verbal instructions (GCS: motor <=5)

Who cannot join

  • traumatic cardiac arrest
  • pregnancy
  • cognitive impairment before cardiac arrest (CPC scale >=3)
  • severe peripheral artery diseases
  • Raynaud's syndrome

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Taiwan1 site
  • National Taiwan University Hospital

    Taipei

    Dean-An Ling, MD, +886-02-23123456, speckle0714@gmail.com

Other trials in Taiwan

About this study

Neurological outcome is the primary outcome for post-cardiac arrest patients. Hypoxic-ischemic brain injury is a key element in post-cardiac arrest syndrome, and remains the leading cause of mortality and morbidity in post-cardiac arrest patients. In patients with hypoxic-ischemic brain injury, impaired cerebral autoregulation makes cerebral blood flow highly vulnerable to blood pressure fluctuations, which might trigger secondary brain injuries. Although the pressure reactivity index (PRx) calculated via invasive intracranial pressure (ICP) monitoring is considered the gold standard for assessing cerebral autoregulation, its clinical application in post-cardiac arrest patients is limited due to invasive risks. Alternatively, cerebral near-infrared spectroscopy (NIRS) combined with hemodynamic monitoring offers a non-invasive approach to measure the cerebral oxygenation index (COx). However, its consistency with invasive methods and its accuracy in post-cardiac arrest care warrant further validation. The aim of this study is to assess cerebral autoregulation via COx calculated with NIRS and hemodynamic parameters in post-cardiac arrest patients, and to analyze the impact of this index on neurological outcomes. The further goal is to estimate optimal mean arterial pressure (MAPopt) and subsequently establish personalized post-resuscitation blood pressure targets.

Medical subject headings
Heart Arrest

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Neurological Outcome

    Cerebral Performance Category Scale (1-5), higher scores mean a worse outcome

    Measured: up to 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Oct 2026
  2. Study startJan 2027 (estimated)
  3. Primary completion31 Jul 2029 (estimated)
  4. Study completion31 Dec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07875348
Sponsor's protocol ID
202606297RINA
Status last verified
Oct 2026
First submitted
5 Oct 2026
Last updated
15 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in